"Le bâtiment "Eveillon" héberge la maternité, les urgences gynécologiques, la réanimation néonatale et la néonatalogie, la chirurgie gynécologique, pelvienne et mammaire. De type 3, la maternité comprend une unité de néonatologie et réanimation néonatale. Elle assure le suivi des grossesses normales mais également des grossesses pathologiques et de leurs accouchements."

During the past decade, Ch Chambery conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 4 clinical trials were completed, i.e. on average, 4.7% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 4 clinical trials were completed. i.e. 10.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ch Chambery" #1 sponsor was "The Lymphoma Academic Research Organisation" with 15 trials, followed by "University Hospital, Grenoble" with 10 trials sponsored, "UNICANCER" with 9 trials sponsored, "Centre Hospitalier Metropole Savoie" with 6 trials sponsored and "Intergroupe Francophone de Cancerologie Thoracique" with 6 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ch Chambery" #1 collaborator was "University Hospital, Grenoble" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Ministry of Health, France" with 3 trials as a collaborator, "Sanofi" with 3 trials as a collaborator and "AGIR à Dom" with 2 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Ch Chambery" are "Multiple Myeloma" (6 trials), "Breast Cancer" (4 trials), "Lymphoma" (4 trials), "COVID-19" (3 trials) and "Covid19" (3 trials). Many other conditions were trialed in "Ch Chambery" in a lesser frequency.

Most popular intervention types in "Ch Chambery" are "Drug" (61 trials), "Other" (30 trials), "Biological" (10 trials), "Device" (9 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Rituximab" (7 trials), "Cyclophosphamide" (4 trials), "Doxorubicin" (4 trials) and "Lenalidomide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ch Chambery" are 123 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Ch Chambery". undefined are not yet recruiting, 30 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Ch Chambery, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Ch Chambery, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 26 trials that are defined as “Not Applicable".

Ch Chambery has several departments that took part in Clinical trials: "Ch De Chambery; Nephrologie" - 2 trials